Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
Apr. 5, 2012—Leonard Folgarait, professor of history of art, delivered the keynote address on Mexican photography at the Art History Graduate Student Symposium held at Duke University. Nancy Godleski has been named assistant dean for collections at Central Library. Previously, Godleski was the Kaplanoff Librarian for American History and American Studies at Yale’s Sterling Memorial Library. Ian...
Mar. 28, 2012—Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.”
Mar. 23, 2012—A new study offers clues on why melanoma patients who are treated with oral drugs inhibiting the BRAF gene are at increased risk for developing secondary skin cancers.
Feb. 23, 2012—Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.
Feb. 3, 2012—Severity of cancer could be predicted by prostate size.
Jan. 13, 2012—A large, retrospective study of the children of childhood cancer survivors who were treated with radiation therapy and/or some forms of chemotherapy found that the offspring do not have an increased risk for birth defects compared with children of cancer survivors who did not receive these treatments.